Argentaffinoma (Argentaffinoma), Carcinoid (Carcinoid)

Argentaffinoma and Carcinoid are rare types of tumors that usually develop in the intestinal glands. They contain argentaffin cells, which can produce various physiologically active substances such as serotonin and prostaglandins. If the tumor spreads to the liver, excess of these substances enters the bloodstream and can cause carcinoid syndrome.

Argentaffinoma usually develops in the upper part of the appendix and small intestine. It can also occur in the rectum and other parts of the digestive tract, as well as in the bronchial tree. Bronchial carcinoid adenoma is another type of tumor that can produce physiologically active substances and cause carcinoid syndrome.

Carcinoid syndrome is a set of symptoms that may include headache, flushing, diarrhea, asthma-like attacks, and damage to the right side of the heart. These symptoms may be caused by an excess of physiologically active substances produced by the tumor. Carcinoid syndrome usually develops when a tumor spreads to the liver.

Treatment for argentaffinoma and carcinoid may vary depending on the extent of the tumor's spread. If the tumor does not spread to other organs, it can be removed surgically. If the tumor has already spread, treatment may include chemotherapy, radiation therapy and other methods.

In conclusion, argentaffinoma and carcinoid are rare types of tumors that can produce physiologically active substances and cause carcinoid syndrome. Treatment depends on the extent of the tumor and may include surgery, chemotherapy, radiation therapy and other methods. If you notice symptoms associated with carcinoid syndrome, contact your doctor for further diagnosis and treatment.

Argentafinoma (AIPOMA) and carcinoma (carcinominous) are two different diseases associated with tumors of the gastrointestinal tract. Despite their differences, both diseases can cause serious clinical symptoms if they are not promptly detected and treated.

Argentaffinoma, also known as carcinoid, is a tumor of the intestinal glands that contains argentaffin cells, which belong to a group of cells known as aminopeptidase, decarboxylase, and diamino acid-utilizing cells. Argentaffinoma usually develops in the upper part of the appendix, but can also often occur in the small intestine. It can occur in other parts of the digestive tract, including the rectum, and also in the bronchial tree, where it is known as bronchial carcinoid adenoma.

One of the characteristic features of argentaffinoma is its ability to produce various physiologically active substances, such as 5-hydroxytryptamine (serotonin) and prostaglandins. However, these substances are usually inactivated by the liver. If the tumor spreads to the liver, excess amounts of these substances can enter the systemic circulation, leading to the development of carcinoid syndrome.

Carcinoid syndrome is characterized by a range of symptoms, including headache, flushing, diarrhea, and attacks that may resemble asthmatic attacks. In some cases, the tumor can affect the right side of the heart, leading to its damage.

The diagnosis of argentaffinoma is usually made through various examination methods, including endoscopy, biopsy, and educational methods such as computed tomography (CT) and magnetic resonance imaging (MRI).

Treatment for argentaffinoma depends on many factors, including the size and location of the tumor, the presence of metastases, and the patient's general condition. In some cases, surgical removal of the tumor may be required. Other treatments may include chemotherapy, radiation therapy, and drug therapy to reduce the symptoms of carcinoid syndrome.

In conclusion, argentaffinoma (carcinoid) is a tumor of the intestinal glands that can occur in various parts of the digestive tract and bronchial tree. It is capable of producing physiologically active substances and can cause the development of carcinoid syndrome. Early detection and adequate treatment play an important role in prognosis and improving the quality of life of patients suffering from argentaffin carcinoid.